Tier 3 · Filer Universe

BioNexus Gene Lab Corp

BGLC · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.

Price
$1.57
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0001737523
Liquidity rank
#6474
Observed dollar volume

Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.

SEC XBRL facts

FieldValuePeriod endFiling
Annual revenue$7.42M2025-12-310001477932-26-002218
Annual diluted EPS-0.092024-12-310001477932-25-002725
Quarterly revenue$76,156.002026-06-300001477932-26-005093
Quarterly diluted EPS-0.122026-06-300001477932-26-005093

SEC EDGAR Frames batch generated 2026-08-24T14:23:45.132Z. Frames are calendar-aligned and may not cover every filer or fiscal period.

Filings and machine access

Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract

Context paths

HealthcareNasdaqDHR · Tier 1 peerBMY · Tier 1 peerABT · Tier 1 peerAMGN · Tier 1 peer

Provenance

IdentitySEC company tickers and Nasdaq Symbol Directory
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames